Charcoal-a low-cost option to treat oleander poisoning

June 05, 2003

Research from Sri Lanka in this week's issue of THE LANCET highlights how repeated doses of charcoal could reduce deaths from oleander-seed poisoning by up to 70%. The authors of the study suggest that charcoal could also be effective in treating poisoning from drugs used in Western populations with similar effects to oleander-seed poisoning, such as digoxin and digitoxin, or with drugs that are eliminated from the body in a similar fashion.

Deliberate self-poisoning with yellow oleander seeds is common in Sri Lanka, causing around 2000 deaths every year. Oleander poisoning results in severe toxicity in the heart and has a death rate of about 10%. Specialised treatment (such as temporary pacemakers and the use of antibodies) is expensive and not available in rural settings. H J de Silva from the University of Kelaniya, Sri Lanka, and colleagues investigated whether multiple-dose charcoal could be a low-cost option for treating oleander poisoning; charcoal causes the binding of harmful glycosides in the gut, thereby aiding in their elimination from the body.

Around 400 people admitted to hospital with oleander poisoning were given one dose of activated charcoal (standard treatment) and then randomly assigned either 50 g of activated charcoal four times a day for 3 days or sterile water (as a placebo). There were significantly fewer deaths in the treatment group (2.5%) compared with those given placebo (8%). Charcoal treatment also resulted in fewer secondary outcomes (life-threatening cardiac arrhythmias, dose of atropine used, need for cardiac pacing, admission to intensive care) than placebo.

H J de Silva comments: "Multiple-dose activated charcoal is safe and effective in reducing death and life-threatening cardiac arrhythmias after yellow oleander poisoning, and should be given to all patients who have ingested yellow oleander seeds. Expensive interventions, such as cardiac pacing and antidigoxin antibody Fab fragments, could be reserved for patients who have dangerous arrhythmias [irregular heart beats] at the time of presentation with poisoning, or those who develop arrhythmias despite treatment with activated charcoal."

Co-investigator Jeff Aronson adds: "Our results suggest that multiple-dose activated charcoal could also be of use in the treatment of patients who have been poisoned with other cardiac glycosides. A previous study in 23 patients and a few anecdotal reports have shown that charcoal increases the clearance rate of digoxin (Lanoxin), and experimental evidence shows much the same effect on digitoxin clearance. Multiple-dose charcoal should also be useful in treating poisoning with other drugs that are eliminated from the body by being secreted into the gut, as the cardiac glycosides are."
-end-
Contact: Dr J K Aronson, University Department of Clinical Pharmacology, Radcliffe Infirmary, Woodstock Road, Oxford OX2 6HE, UK;
T) 44-186-522-4626;
F) 44-186-579-1712;
E) jeffrey.aronson@clinpharm.ox.ac.uk. (Sri Lanka)

Dr H J de Silva, Department of Medicine, Faculty of Medicine, University of Kelaniya, PO Box 6, Thalagolla Road, Ragama, Sri Lanka;
F)94-195-8337;
E) asitades@hotmail.com

Lancet

Related Drugs Articles from Brightsurf:

The danger of Z-drugs for dementia patients
Strong sleeping pills known as 'Z-drugs' are linked with an increased risk of falls, fractures and stroke among people with dementia, according to new research.

Wallflowers could lead to new drugs
Plant-derived chemicals called cardenolides - like digitoxin - have long been used to treat heart disease, and have shown potential as cancer therapies.

Bristol pioneers use of VR for designing new drugs
Researchers at the University of Bristol are pioneering the use of virtual reality (VR) as a tool to design the next generation of drug treatments.

Towards better anti-cancer drugs
The Bayreuth biochemist Dr. Claus-D. Kuhn and his research team have deciphered how the important human oncogene CDK8 is activated in cells of healthy individuals.

Separating drugs with MagLev
The composition of suspicious powders that may contain illicit drugs can be analyzed using a quick and simple method called magneto-Archimedes levitation (MagLev), according to a new study published in the journal Angewandte Chemie.

People are more likely to try drugs for the first time during the summer
American teenagers and adults are more likely to try illegal or recreational drugs for the first time in the summer, a new study shows.

Drugs used to enhance sexual experiences, especially in UK
Combining drugs with sex is common regardless of gender or sexual orientation, reveals new research by UCL and the Global Drug Survey into global trends of substance-linked sex.

Promising new drugs for old pathogen Mtb
UConn researchers are targeting a metabolic pathway, the dihydrofolate reductase pathway, crucial for amino acid synthesis to treat TB infections.

Can psychedelic drugs heal?
Many people think of psychedelics as relics from the hippie generation or something taken by ravers and music festival-goers, but they may one day be used to treat disorders ranging from social anxiety to depression, according to research presented at the annual convention of the American Psychological Association.

New uses for existing antiviral drugs
Broad-spectrum antiviral drugs work against a range of viral diseases, but developing them can be costly and time consuming.

Read More: Drugs News and Drugs Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.